These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37584110)

  • 1. Correlation of desmoglein 1 and 3 immunohistochemistry with autoantibody levels and clinical severity in pemphigus.
    Pradeep A; Eapen M; Jagadeeshan S; Kani K
    J Cutan Pathol; 2023 Dec; 50(12):1104-1109. PubMed ID: 37584110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diagnostic value of indirect immunofluorescence assay and desmoglein ELISA in the diagnosis of pemphigus.
    Marinović B; Fabris Z; Lipozencić J; Stulhofer Buzina D; Lakos Jukić I
    Acta Dermatovenerol Croat; 2010; 18(2):79-83. PubMed ID: 20624356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
    Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
    Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus.
    Vernal S; Julio TA; Alves FH; Turatti A; Donadi EA; Roselino AM
    An Bras Dermatol; 2024; 99(5):680-687. PubMed ID: 38851894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of cutaneous-type pemphigus vulgaris and a case of pemphigus foliaceus without mucosal involvement despite high anti-desmoglein 3 autoantibody levels.
    Terada A; Akasaka E; Nakano H; Sawamura D
    J Dermatol; 2023 Nov; 50(11):1501-1505. PubMed ID: 37485682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
    Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
    J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3.
    Harman KE; Gratian MJ; Seed PT; Bhogal BS; Challacombe SJ; Black MM
    Clin Exp Dermatol; 2000 May; 25(3):236-40. PubMed ID: 10844505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
    Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression and response to therapy in pemphigus based on a registry.
    Pieper J; Pollmann R; Eming R; Greene B; Hahmann M; Hertl M
    J Dtsch Dermatol Ges; 2022 Apr; 20(4):461-467. PubMed ID: 35446493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay.
    Komai A; Amagai M; Ishii K; Nishikawa T; Chorzelski T; Matsuo I; Hashimoto T
    Br J Dermatol; 2001 Jun; 144(6):1177-82. PubMed ID: 11422038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.
    Daneshpazhooh M; Kamyab K; Kalantari MS; Balighi K; Naraghi ZS; Shamohammadi S; Mortazavizadeh SM; Ramezani A; Chams-Davatchi C
    Clin Exp Dermatol; 2014 Jan; 39(1):41-7. PubMed ID: 23782219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris.
    Sami N; Bhol KC; Ahmed RA
    Eur J Dermatol; 2003; 13(4):377-81. PubMed ID: 12948919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acantholysis may precede elevation of circulating anti-desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis.
    Endo H; Rees TD; Niwa H; Kuyama K; Oshima M; Serizawa T; Tanaka S; Komiya M; Ito T
    Clin Exp Dent Res; 2019 Jun; 5(3):219-224. PubMed ID: 31249702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
    Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
    Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
    Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
    J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
    Cheng SW; Kobayashi M; Kinoshita-Kuroda K; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2002 Aug; 147(2):261-5. PubMed ID: 12174096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
    Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus.
    Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN
    J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.